Faculty

Pharmacist by education and a PhD on cyclosporine in kidney transplants (1999). Head of Laboratory for Renal Physiology at Oslo University Hospital – Rikshospitalet and professor at University of Oslo, Norway. Research leader of the group for Transplantation Medicine research at Oslo University Hospital – Rikshospitalet, Oslo, Norway. CEO for the Norwegian Renal Registry, a national medical quality registry.

Has more than 30 years of research experience in kidney transplantation, with a special focus on pharmacokinetics and population models for improved diagnostics and dosing of patients. Lead both national- and internation clinical trials, including the VICTOR CMV-treatment trial in solid organ transplantation.

Ilkka Helanterä, MD, PhD, works as a transplant nephrologist at the Helsinki University Hospital abdominal transplant center and is an adjunct professor of nephrology at the University of Helsinki.

His research interests are focused on kidney transplantation with both epidemiological and molecular aspects, with special interests on viral infections, especially CMV.

He is a former associate editor of Transplant International, and is currently an associate editor and director of the Editorial Fellowship Program in American Journal of Transplantation.

He is a working group member of the Scandiatranslant Infectious diseases committee and ECDC solid-organ transplant infectious disease network (SoHO-Net). In addition, he has been a member of the Transplantation Society’s most recent consensus guidelines groups for both CMV and BKPyV infections after solid-organ transplantation."

Hermione Lyall
Retired Consultant in Paediatric Infectious Diseases at
Imperial College Healthcare NHS Trust.
Visiting Professor of Paediatric Infectious Diseases at Imperial College.

I am a retired consultant in Paediatric Infectious Diseases at Imperial College Healthcare NHS Trust and Visiting Professor of Paediatric Infectious Diseases at Imperial College. I have retired from clinical work, but continue with an honorary contract at Imperial College Healthcare NHS Trust. I am a member of PENTA-ID and have participated in HIV treatment and prevention trials for children. I have been actively involved in education for Paediatric Infections for many years, working with PENTA and ESPID.

In 2020, with colleagues from around Europe, we set up CCMVNET ([email protected]) an international network built around a prospective registry for children with congenital CMV (CCMV). I was the inaugural chair of the network (2020-2023). Our aim is to learn as much as possible about CCMV, and promote collaboration for research into prevention and treatment. Bringing together – children, families and peer supporters, clinicians, laboratory scientists, epidemiologists, virologists, pharmacologists, and trialists – all the team that we need to change the future for children with CCMV.